ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

HG

Hospital General Universitario Gregorio Marañón at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital General Universitario Gregorio Marañón takes part in 14 sessions at ESMO 2026 in Madrid, its home city. Its program covers treatment decisions and molecular testing across breast, lung and gastrointestinal cancers. Topics include using tumour sequencing to guide treatment and genetic counselling in bile duct cancers.

OrganizationESMO 2026 Attendance
HG
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Cancer centre & hospital
Public general university hospital in Madrid, Spain, affiliated with the Complutense University of Madrid.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Characterization of localized anal cancer patients in Spanish TTD-RETUD registry
ePoster session 19
Gastrointestinal cancers
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Hybrid-capture next-generation sequencing as a screening tool for germline genomic alterations in PDAC
ePoster session 16
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Impact of tumor next-generation sequencing (NGS) on treatment decision and genetic counseling referral in biliary tract cancers (BTC)
ePoster session 2
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Satellite
Sun Oct 25
13:25–13:45
Evaluating oral SERDs in adjuvant endocrine therapy: Current evidence and clinical trials
F. Hoffmann - La Roche LTD - Next-era strategies in HR+ HER2– early breast cancer: Optimising endocrine therapy
Breast cancer
Satellite
Sun Oct 25
13:27–13:52
Shaping long-term outcomes in first-line treatment for EGFR-mutant NSCLC
Johnson & Johnson - Transforming the Treatment Journey in EGFR- Mutant NSCLC · with European Institute of Oncology (IEO)
Lung & thoracic cancers
Satellite
Sun Oct 25
18:30–20:00
Satellite
Sun Oct 25
18:30–18:40
Welcome & Introduction
Daiichi Sankyo - Patient Identification in NSCLC: 10 From Actionable Genomic Alterations to Emerging ADC Opportunities
Lung & thoracic cancersBiomarkers & precision oncology
Satellite
Sun Oct 25
18:55–19:20
Adjuvant Treatment Approaches for Early-stage Melanoma
Regeneron - Perspectives on Early-stage Melanoma: Diagnosis, Staging, and Treatment
Melanoma & skin cancers
Satellite
Sun Oct 25
19:40–20:00
Audience Q&A and Panel Discussion
Regeneron - Perspectives on Early-stage Melanoma: Diagnosis, Staging, and Treatment · with University Hospital Schleswig-Holstein, Melanoma Institute Australia
Melanoma & skin cancers
Satellite
Sun Oct 25
19:40–20:00
Audience Q&A, Key Takeaways, and Close
Daiichi Sankyo - Patient Identification in NSCLC: 10 From Actionable Genomic Alterations to Emerging ADC Opportunities
Lung & thoracic cancersBiomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Hospital General Universitario Gregorio Marañón

Tell us what you sell and we’ll find the people at Hospital General Universitario Gregorio Marañón most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction